IMA Advisory Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108K Buy
1,602
+1,502
+1,502% +$100K 0.01% 411
2026
Q1
$6.28K Hold
100
– – ﹤0.01% 369
2025
Q4
$6.64K Hold
100
– – ﹤0.01% 372
2025
Q3
$6.73K Hold
100
– – ﹤0.01% 326
2025
Q2
$8.73K Hold
100
– – ﹤0.01% 313
2025
Q1
$6.83K Buy
+100
New +$8.16K ﹤0.01% 315
2024
Q4
– Sell
-100
Closed -$6.7K – 207
2024
Q3
$6.7K Buy
+100
New +$8.21K ﹤0.01% 248
2022
Q4
– Sell
-4
Closed – – 376
2022
Q3
$0 Buy
+4
New +$339 ﹤0.01% 355

Other funds holding DXCM

IMA Advisory Services's DXCM Position: Q2 2026 in Review

IMA Advisory Services increased its DexCom (DXCM) stake by 1,502% in Q2 2026, buying an estimated $100K and bringing the position to 1,602 shares worth $108K. The position accounts for 0.01% of the portfolio, ranked #411.

IMA Advisory Services first reported a position in DXCM in Q3 2022 and has held it in 8 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • IMA Advisory Services held 1,602 shares of DexCom worth $108K as of Q2 2026.
  • IMA Advisory Services bought 1,502 DexCom shares in Q2 2026, an estimated $100K.
  • DexCom made up 0.01% of IMA Advisory Services's portfolio in Q2 2026, its #411 holding.
  • IMA Advisory Services first reported a position in DexCom in Q3 2022 and has held it in 8 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.